AlzeCure Pharma
2.43 SEK
+1.25 %
Less than 1K followers
ALZCUR
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+1.25 %
+22.42 %
-31.16 %
-25.44 %
+122.39 %
+110.49 %
-39.47 %
-71.19 %
-74.34 %
AlzeCure Pharma is a pharmaceutical company that researches and develops small molecule drug candidates for the treatment of diseases of the central nervous system, with a particular focus on Alzheimer's and chronic pain. The company is developing several parallel projects where the technology and research are based on its own drug platform. AlzeCure Pharma is headquartered in Huddinge, Sweden.
Read moreMarket cap
279.24M SEK
Turnover
75.5K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26.2
2026
Annual report '25
5.5
2026
Interim report Q1'26
14.5
2026
General meeting '26
All
Press releases
3rd party
ShowingAll content types
Redeye: AlzeCure Pharma (Q3 Review) - Clinical phase IIa study in focus
AlzeCure publishes its interim report for January – September 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools